WPC
VYNT

White Pine Capital’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

White Pine Capital’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-181
Closed -$374K – 234
2013
Q4 		$374K Buy
+181
New +$391K 0.13% 164

Other funds holding VYNT

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Castleark Management
Castleark Management Chicago, Illinois $3.71B AUM 65.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Driehaus Capital Management
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
GMCM
Gruber & McBaine Capital Management San Francisco, California $369M AUM 12.23% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Sterneck Capital Management Kansas City, Missouri $233M AUM 21.98% 1-Year Est. Return

White Pine Capital's VYNT Position: Q1 2014 in Review

White Pine Capital sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2014, closing a stake of 181 shares — an estimated $374K sold.

White Pine Capital first reported a position in VYNT in Q4 2013 and held it in 1 quarter. The position peaked at $374K in Q4 2013. 32 funds tracked by Wall St. Rank hold VYNT as of Q1 2014.

  • White Pine Capital reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • White Pine Capital sold 181 Vyant Bio, Inc. Common Stock shares in Q1 2014, an estimated $374K.
  • White Pine Capital first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • White Pine Capital's Vyant Bio, Inc. Common Stock position peaked at $374K in Q4 2013.
  • 32 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2014.

Based on White Pine Capital's 13F filing for Q1 2014, filed 14 May 2014.